...
首页> 外文期刊>Helvetica chimica acta >Synthesis and spectroscopic characterization of 4-chlorophenyl isocyanate (= 1-chloro-4-isocyanatobenzene) adducts with amino acids as potential dosimeters for the biomonitoring of isocyanate exposure
【24h】

Synthesis and spectroscopic characterization of 4-chlorophenyl isocyanate (= 1-chloro-4-isocyanatobenzene) adducts with amino acids as potential dosimeters for the biomonitoring of isocyanate exposure

机译:氨基酸为潜在剂量计的异氰酸酯生物监测的4-氯苯基异氰酸酯(= 1-氯-4-异氰酸根合苯)加合物的合成和光谱表征

获取原文
获取原文并翻译 | 示例
           

摘要

Blood-protein adducts are used as dosimeter for modifications of macromolecules in the target organs where the disease develops. The functional groups of cysteine, tyrosine, serine, lysine, tryptophan, histidine and N-terminal amino acids are potential reaction sites for isocyanates. Especially the N-terminal amino acids, valine and aspartic acid of hemoglobin and albumin, respectively, are reactive towards electrophilic xenobiotics. To develop methods for the quantification of such blood-protein adducts, we treated 4-chlorophenyl isocyanate (1) with the tripeptide L-valyl-glycyl-glycine (2a) a nd with single amino acids yielding N-[(4-chlorophenyl)carbamoyl]valyl-glycyl-glycine (3a), N-[(4-chlorophenyl)carbamoyl]valine (3b), N-[(4-chlorophenyl)carbamoyl]aspartic acid (3c), N-[(4-chlorophenyl)carbamoyl]glutamic acid (3d), N-acetyl-S-[(4-chlorophenyl)carbamoyl]cysteine (3e), and N-acetyl-O-[(4-chlorophenyl)carbamoyl]serine (3f), N-alpha-acetyl-N-epsilon-[(4-chlorophenyl)carbamoyl]lysine (3g). For several chemicals, it was shown that blood-protein adducts are good dosimeters of exposure and dosimeters for the target dose. The hydrolysis of the N-terminal adducts of isocyanates release hydantoins which can be separated From the rest of the protein and analyzed using GC/MS or HPLC. This was achieved with 3a. The released hydantoin could be analyzed using GC/MS. We propose to analyze the N-terminal adducts of isocyanates with blood protein to distinguish between arenamine and arylisocyanate exposure. [References: 46]
机译:血液蛋白加合物用作剂量计,用于在疾病发展的目标器官中修饰大分子。半胱氨酸,酪氨酸,丝氨酸,赖氨酸,色氨酸,组氨酸和N-末端氨基酸的官能团是异氰酸酯的潜在反应位点。尤其是血红蛋白和白蛋白的N末端氨基酸,缬氨酸和天冬氨酸分别对亲电子异生物具有反应性。为了开发定量这种血蛋白加合物的方法,我们用三肽L-戊基-甘氨酰-甘氨酸(2a)处理了4-氯苯基异氰酸酯(1),并用单个氨基酸生成了N-[(4-氯苯基)氨基甲酰基]戊基-甘氨酰-甘氨酸(3a),N-[(4-氯苯基)氨基甲酰基]缬氨酸(3b),N-[(4-氯苯基)氨基甲酰基]天冬氨酸(3c),N-[(4-氯苯基)氨基甲酰基]谷氨酸(3d),N-乙酰基-S-[(4-氯苯基)氨基甲酰基]半胱氨酸(3e)和N-乙酰基-O-[(4-氯苯基)氨基甲酰基]丝氨酸(3f),N-α -乙酰基-N-ε-[(4-氯苯基)氨基甲酰基]赖氨酸(3g)。对于几种化学物质,已表明血蛋白加合物是良好的暴露剂量计和目标剂量的剂量计。异氰酸酯N末端加合物的水解释放出乙内酰脲,后者可与蛋白质的其余部分分离并使用GC / MS或HPLC分析。这是通过3a实现的。可以使用GC / MS分析释放的乙内酰脲。我们建议分析异氰酸酯与血液蛋白的N末端加合物,以区分芳胺和芳基异氰酸酯暴露量。 [参考:46]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号